PNC Financial Services Group’s Ovid Therapeutics OVID Stock Holding History

PNC Financial Services Group’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.43K	Hold	903	–	–	﹤0.01%	4611
2026 Q1	$2K	Hold	903	–	–	﹤0.01%	4578
2025 Q4	$1.47K	Hold	903	–	–	﹤0.01%	4600
2025 Q3	$1.17K	Hold	903	–	–	﹤0.01%	4641
2025 Q2	$298	Buy	903 +897	+14,950%	+$270	﹤0.01%	4758
2025 Q1	$2	Sell	6 -255	-98%	-$157	﹤0.01%	4880
2024 Q4	$244	Buy	+261	New	+$292	﹤0.01%	4629
2024 Q1	–	Sell	-10	Closed	-$32	–	4782
2023 Q4	$32	Buy	+10	New	+$34	﹤0.01%	4587
2022 Q4	–	Sell	-2,000	Closed	-$4K	–	4833
2022 Q3	$4K	Hold	2,000	–	–	﹤0.01%	4027
2022 Q2	$4K	Buy	+2,000	New	+$4.83K	﹤0.01%	4057

Other funds holding OVID

Jupiter Topco New York $245B AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PNC Financial Services Group's OVID Position: Q2 2026 in Review

PNC Financial Services Group held its Ovid Therapeutics (OVID) position steady in Q2 2026 at 903 shares worth $2.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4611.

PNC Financial Services Group first reported a position in OVID in Q2 2022 and has held it in 10 quarters since. The position peaked at $4K in Q3 2022. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

PNC Financial Services Group held 903 shares of Ovid Therapeutics worth $2.43K as of Q2 2026.
PNC Financial Services Group left its Ovid Therapeutics share count unchanged in Q2 2026.
Ovid Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4611 holding.
PNC Financial Services Group first reported a position in Ovid Therapeutics in Q2 2022 and has held it in 10 quarters since.
PNC Financial Services Group's Ovid Therapeutics position peaked at $4K in Q3 2022.
130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.